Current status of radioimmunotherapy

This publication has 17 references indexed in Scilit:

• Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.
  Journal of Clinical Oncology, 1993
• A Model for Others: A Strategy for Improving Diagnosis and Therapy of Human Malignancies Using Monoclonal Antibodies Targeting TAG72 Oncofetal Antigen
  Cancer Investigation, 1993
• Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
  Journal of Clinical Oncology, 1992
• Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: Current status and future perspectives
  The American Journal of Surgery, 1992
• Radiolabeled Antibody Therapy of Human B Cell Lymphomas
  Published by Springer Nature ,1991
• Intraperitoneal radioimmunotherapy for ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1989
• Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: Preliminary results of experimental and clinical studies
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Intraperitoneal131I- and90-labelled monoclonal antibodies for ovarian cancer: Pharmacokinetics and normal tissue dosimetry
  International Journal of Cancer, 1988
• Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.
  Journal of Clinical Oncology, 1987
• Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
  Journal of Clinical Investigation, 1983